Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases: A double-blind, randomized dose-response study

James R. Berenson, Lee S. Rosen, Anthony Howell, Lester Porter, Robert E. Coleman, Walter Morley, Robert Dreicer, Steven A. Kuross, Allan Lipton, John J. Seaman

Research output: Contribution to journalArticlepeer-review

464 Scopus citations

Fingerprint Dive into the research topics of 'Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases: A double-blind, randomized dose-response study'. Together they form a unique fingerprint.

Medicine & Life Sciences